Analyst Ratings for Ascendis Pharma (ASND)
ASND Rating Summary
ASND Price Target Summary
- Highest: $342.00 (Barclays)
- Lowest: $84.00 (Canaccord)
- Average: $278.12
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$278.12 (+15.6%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
Avg. $ Target:
$278.12 (+15.6%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
342.00 (N/A) |
233.65 (240.65) |
3% | Details |
| 11/18/2025 | Wolfe Research » Updated 3/2/2026 |
Kalpit Patel | New Coverage | Outperform (N/A) |
260.00 (255.00) |
204.40 (240.65) |
17.73% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
